iCad names Stacey Stevens as CEO

iCad (NSDQ:ICAD) today announced that it has appointed Stacey Stevens as president and CEO, effective March 1, 2022.

Stevens has served as the Nashua, N.H.-based company’s president since 2019. She succeeds chairperson and CEO Michael Klein, who will continue to serve as chairperson of iCad’s board of directors.

“On behalf of the entire board of directors, I would like to congratulate Ms. Stevens on this appointment. It has been a privilege to work closely with her for the past three years, as she brings a relentless focus on leading change and a proven track record of driving growth and innovation. I look forward to continued interaction in her new capacity as CEO,” Klein said in a news release. “We are currently at an important inflection point, with the recent launch of several first-in-kind technologies and the Company’s increasing focus on enterprise sales on the Detection side of the business, and with the expansion of Xoft in emer…

Read more
  • 0

Latest iCad 3D mammography AI gains CE mark

iCad’s latest AI for digital breast tomosynthesis provides a case score for each detection. (Image courtesy of iCad)

iCad (NSDQ:ICAD) today announced that the third version of its ProFound AI for digital breast tomosynthesis (DBT) has won CE mark approval.

Compared with previous software versions, the latest generation of ProFound AI offers up to a 10% improvement in specificity performance while maintaining a high sensitivity level, and approximately 40% faster processing on the new PowerLook platform, according to the Nashua, N.H.–based company.

Get the full story on our sister site, Medical Design & Outsourcing

Read more
  • 0